Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Doss

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Organic Letters|May 25, 2002
Novel fragmentation reaction of correolideJianming Bao, Robert K Baker, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometryDavid Q Liu, Bindhu V Karanam, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slicesR A Stearns, R R Miller, G A Doss, et al.
Organic Letters|January 28, 2005
Estrogen receptor ligands. 12. Synthesis of the major metabolites of an ERalpha-selective, dihydrobenzoxathiin antagonist for osteoporosisSeongkon Kim, Jane Y Wu, Zhoupeng Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2004
Identification and metabolism of a novel dihydrohydroxy-S-glutathionyl conjugate of a peroxisome proliferator-activated receptor agonist, MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], in ratsVijay Bhasker G Reddy, George A Doss, Mellissa Creighton, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Wobbly hedgehog syndrome- a progressive neurodegenerative diseaseGrayson A Doss, Daniel Z Radecki, Arya Kethireddy, et al.
Experimental Neurology|August 27, 2023
Wobbly hedgehog syndrome- a progressive neurodegenerative diseaseGrayson A Doss, Daniel Z Radecki, Arya Kethireddy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1996
Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical speciesK H Leung, D A Cohn, R R Miller, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|August 25, 2021
Development and Testing of a Sedation Scale for Use in Rabbits (<i>Oryctolagus cuniculus</i>)Juliette Raulic, Vivian Sy Leung, Grayson A Doss, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 1, 2002
Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detectionC Z Matthews, E J Woolf, R S Mazenko, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Organic Letters|May 25, 2002
Novel fragmentation reaction of correolideJianming Bao, Robert K Baker, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometryDavid Q Liu, Bindhu V Karanam, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slicesR A Stearns, R R Miller, G A Doss, et al.
Organic Letters|January 28, 2005
Estrogen receptor ligands. 12. Synthesis of the major metabolites of an ERalpha-selective, dihydrobenzoxathiin antagonist for osteoporosisSeongkon Kim, Jane Y Wu, Zhoupeng Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2004
Identification and metabolism of a novel dihydrohydroxy-S-glutathionyl conjugate of a peroxisome proliferator-activated receptor agonist, MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], in ratsVijay Bhasker G Reddy, George A Doss, Mellissa Creighton, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Wobbly hedgehog syndrome- a progressive neurodegenerative diseaseGrayson A Doss, Daniel Z Radecki, Arya Kethireddy, et al.
Experimental Neurology|August 27, 2023
Wobbly hedgehog syndrome- a progressive neurodegenerative diseaseGrayson A Doss, Daniel Z Radecki, Arya Kethireddy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1996
Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical speciesK H Leung, D A Cohn, R R Miller, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|August 25, 2021
Development and Testing of a Sedation Scale for Use in Rabbits (<i>Oryctolagus cuniculus</i>)Juliette Raulic, Vivian Sy Leung, Grayson A Doss, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 1, 2002
Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detectionC Z Matthews, E J Woolf, R S Mazenko, et al.
Pageof 13